Protagenic Therapeutics, Inc.\new Quarterly Return On Assets in % from Q2 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Protagenic Therapeutics, Inc.\new quarterly/annual Return On Assets history and growth rate from Q2 2015 to Q3 2024.
  • Protagenic Therapeutics, Inc.\new Return On Assets for the quarter ending September 30, 2024 was -229 %, a 309% decline year-over-year.
  • Protagenic Therapeutics, Inc.\new annual Return On Assets for 2023 was -82.2 %, a 103% decline from 2022.
  • Protagenic Therapeutics, Inc.\new annual Return On Assets for 2022 was -40.5 %, a 21.7% increase from 2021.
  • Protagenic Therapeutics, Inc.\new annual Return On Assets for 2021 was -51.7 %, a 80.4% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -229 -173 -309% Jul 1, 2024 Sep 30, 2024
Q2 2024 -186 -141 -315% Apr 1, 2024 Jun 30, 2024
Q1 2024 -125 -89.5 -253% Jan 1, 2024 Mar 31, 2024
Q4 2023 -82.2 -41.7 -103% Oct 1, 2023 Dec 31, 2023
Q3 2023 -56 -15.6 -38.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -44.8 -8.17 -22.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -35.3 +6.66 +15.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -40.5 +11.2 +21.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -40.3 +26.7 +39.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -36.6 +85.8 +70.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -42 +357 +89.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -51.7 +213 +80.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -67.1 +224 +76.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -122 +116 +48.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -399 -108 -36.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -264 +95.8 +26.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -291 +108 +27% Jul 1, 2020 Sep 30, 2020
Q2 2020 -239 +107 +31% Apr 1, 2020 Jun 30, 2020
Q1 2020 -291 +24 +7.62% Jan 1, 2020 Mar 31, 2020
Q4 2019 -360 -119 -49.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -398 -213 -115% Jul 1, 2019 Sep 30, 2019
Q2 2019 -346 -199 -135% Apr 1, 2019 Jun 30, 2019
Q1 2019 -315 -204 -184% Jan 1, 2019 Mar 31, 2019
Q4 2018 -241 -143 -146% Oct 1, 2018 Dec 31, 2018
Q3 2018 -185 -105 -131% Jul 1, 2018 Sep 30, 2018
Q2 2018 -148 -76.7 -108% Apr 1, 2018 Jun 30, 2018
Q1 2018 -111 -45.1 -68.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 -98 -34.3 -53.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -79.9 -12.5 -18.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -70.8 +27 +27.6% Apr 1, 2017 Jun 30, 2017
Q1 2017 -65.9 +80.3 +54.9% Jan 1, 2017 Mar 31, 2017
Q4 2016 -63.7 +782 +92.5% Oct 1, 2016 Dec 31, 2016
Q3 2016 -67.4 +715 +91.4% Jul 1, 2016 Sep 30, 2016
Q2 2016 -97.8 +185 +65.4% Apr 1, 2016 Jun 30, 2016
Q1 2016 -146 Jan 1, 2016 Mar 31, 2016
Q4 2015 -846 Oct 1, 2015 Dec 31, 2015
Q3 2015 -782 Jul 1, 2015 Sep 30, 2015
Q2 2015 -283 Apr 1, 2015 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.